Inhaled PGE1 in neonates with hypoxemic respiratory failure: Two pilot feasibility randomized clinical trials

Trials

Volumn 15, Issue 1, 2014, Pages

  Sood, Beena G ^a   Keszler, Martin ^b   Garg, Meena ^c   Klein, Jonathan M ^d   Ohls, Robin ^e   Ambalavanan, Namasivayam ^f   Cotten, C Michael ^g   Malian, Monica ^a   Sanchez, Pablo J ^h   Lakshminrusimha, Satyan ⁱ   Nelin, Leif D ^j   Van Meurs, Krisa P ^k   Bara, Rebecca ^a   Saha, Shampa ^l   Das, Abhik ^l   Wallace, Dennis ^l   Higgins, Rosemary D ^m   Shankaran, Seetha ^a   Besner, Gail E ⁿ   Luzader, Patricia ⁿ   Chicoine, Louis G ⁿ   Gabrio, Jenna ^l   O'Donnell Auman, Jeanette ^l   Zaterka Baxter, Kristin M ^l   Stevenson, David K ^o   Bethany Ball, M ^o   Chinn, Steven ^o   Proud, Melinda S ^o   Carlo, Waldemar A ^f   Collins, Monica V ^f   Cosby, Shirley S ^f   Davis, Zahra ^f   Quinn, Rebecca J ^f   Denson, Brenda Reed ^f   Devaskar, Uday ^p   Chanlaw, Teresa ^p   Geller, Rachel ^p   Bell, Edward F ^q   Widness, John A ^q   Johnson, Karen J ^q   Campbell, Donia B ^q   Colaizy, Tarah T ^q   Dagle, John M ^q   Ellsbury, Dan L ^q   Johnson, Kristine M ^q   Messina, Lynn ^q   Nohr, Joanna L ^q   Watterberg, Kristi L ^e   Lacy, Conra Backstrom ^e   Morgan, Nancy A ^e   D'Angio, Carl T ^r   Guillet, Ronnie ^r   Chess, Patricia ^r   Bean, Stephen A ^r   Cole, Carol A ^r   Heine, Ann Marie ^r   Jensen, Rosemary ^r   Sacilowski, Michael G ^r   Wynn, Karen ^r   Conway, Patrick ^r   Wadkins, Holly I M ^r   Williams, Ashley ^r   Brion, Luc P ^s   Chen, Lijun ^s   Finley, Andre ^s   Meeks, Tram DoNguyen ^s   Merryman, Ruth ^s   Metoyer, Glenn ^s   Mozaffari, Azadeh ^s   Vasil, Diana M ^s   Walsh, Brian ^s   Galli, Robert J ^t   Batts, Maria ^t   Lulic Botica, Mirjana ^t   more..

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ UNIVERSITY AT BUFFALO   (United States)

^j NATIONWIDE CHILDREN S HOSPITAL   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l RTI INTERNATIONAL   (United States)

^m EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁿ THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^o STANFORD UNIVERSITY   (United States)

^p MATTEL CHILDREN S HOSPITAL   (United States)

^q UNIVERSITY OF IOWA   (United States)

^r UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^s UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^t WAYNE STATE UNIVERSITY   (United States)

more..

Author keywords

Aerosols; Clinical trial; Hypoxemic respiratory failure; Nebulizers; Neonatal; Prostaglandins; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PLACEBO; PROSTAGLANDIN E1; SODIUM CHLORIDE; AEROSOL; VASODILATOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; EXTRACORPOREAL OXYGENATION; FEASIBILITY STUDY; FEVER; HUMAN; HYPOTENSION; INFANT; LOW DRUG DOSE; MULTICENTER STUDY; NEONATAL HYPOXEMIC RESPIRATORY FAILURE; NEWBORN; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; TREATMENT DURATION; TREATMENT OUTCOME; AEROSOL; CLINICAL TRIAL; EARLY TERMINATION OF CLINICAL TRIAL; HYPOXIA; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PATIENT SELECTION; PERSISTENT FETAL CIRCULATION SYNDROME; RESPIRATORY INSUFFICIENCY; SAMPLE SIZE; TIME FACTOR; UNITED STATES;

ADMINISTRATION, INHALATION; AEROSOLS; ALPROSTADIL; EARLY TERMINATION OF CLINICAL TRIALS; FEASIBILITY STUDIES; HUMANS; HYPOXIA; INFANT, NEWBORN; PATIENT SELECTION; PERSISTENT FETAL CIRCULATION SYNDROME; PILOT PROJECTS; RESPIRATORY INSUFFICIENCY; SAMPLE SIZE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASODILATOR AGENTS;

EID: 84928575200     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-486     Document Type: Article

References (49)

1. Roberts JD Jr, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM: Inhaled nitric oxide and persistent pulmonary hypertension of the newborn: the inhaled nitric oxide study group. N Engl J Med 1997, 336:605-610. 10.1056/NEJM199702273360902
2. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn: clinical inhaled nitric oxide research group. N Engl J Med 2000, 342:469-474. 10.1056/NEJM200002173420704
3. Truog WE, Castor CA, Sheffield MJ: Neonatal nitric oxide use: predictors of response and financial implications. J Perinatol 2003, 23:128-132. 10.1038/sj.jp.7210864
4. NINOS: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure: the neonatal inhaled nitric oxide study group. N Engl J Med 1997, 336:597-604.
5. Krieg P, Wahlers T, Giess W, Rohde R, Hartrumpf M, Bund M, Haverich A: Inhaled nitric oxide and inhaled prostaglandin E1: effect on left ventricular contractility when used for treatment of experimental pulmonary hypertension. Eur J Cardiothorac Surg 1998, 14:494-502. 10.1016/S1010-7940(98)00210-3
6. Walmrath D, Schermuly R, Pilch J, Grimminger F, Seeger W: Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J 1997, 10:1084-1092. 10.1183/09031936.97.10051084
7. Kumar VH, Swartz DD, Rashid N, Lakshminrusimha S, Ma C, Ryan RM, Morin FC III: Prostacyclin and milrinone by aerosolization improve pulmonary hemodynamics in newborn lambs with experimental pulmonary hypertension. J Appl Physiol 2010, 109:677-684. 10.1152/japplphysiol.01082.2009
8. Putensen C, Hormann C, Kleinsasser A, Putensen-Himmer G: Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 157:1743-1747. 10.1164/ajrccm.157.6.9609017
9. Olschewski H, Simonneau G, Galie N, Higenbottam T, Naeije R, Rubin LJ, Nikkho S, Speich R, Hoeper MM, Behr J, Winkler J, Sitbon O, Popov W, Ghofrani HA, Manes A, Kiely DG, Ewert R, Meyer A, Corris PA, Delcroix M, Gomez-Sanchez M, Siedentop H, Seeger W: Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002, 347:322-329. 10.1056/NEJMoa020204
10. Meyer J, Theilmeier G, Van Aken H, Bone HG, Busse H, Waurick R, Hinder F, Booke M: Inhaled prostaglandin E1 for treatment of acute lung injury in severe multiple organ failure. Anesth Analg 1998, 86:753-758.
11. Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH: Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension. J Am Coll Cardiol 2008, 51:161-169. 10.1016/j.jacc.2007.09.031
12. Sood BG, Delaney-Black V, Aranda JV, Shankaran S: Aerosolized PGE1: a selective pulmonary vasodilator in neonatal hypoxemic respiratory failure results of a Phase I/II open label clinical trial. Pediatr Res 2004, 56:579-585. 10.1203/01.PDR.0000139927.86617.B6
13. Hsiao R, Omar SA: Inhaled aerosolized Prostacyclin (IAP) fpr premature infants with PPHN. Pediatr Res 2004, 55:544A.
14. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH: Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002, 141:830-832. 10.1067/mpd.2002.129849
15. De Luca D, Cogo P, Zecca E, Piastra M, Pietrini D, Tridente A, Conti G, Carnielli VP: Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review. Eur Respir J 2011, 37:678-689. 10.1183/09031936.00024910
16. van Heerden PV, Caterina P, Filion P, Spagnolo DV, Gibbs NM: Pulmonary toxicity of inhaled aerosolized prostacyclin therapy-an observational study. Anaesth Intensive Care 2000, 28:161-166.
17. Wasserman MA, Griffin RL, Marsalisi FB: Inhibition of bronchoconstriction by aerosols of prostaglandins E1 and E2. J Pharmacol Exp Ther 1980, 214:68-73.
18. Borok Z, Gillissen A, Buhl R, Hoyt RF, Hubbard RC, Ozaki T, Rennard SI, Crystal RG: Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis 1991, 144:1080-1084. 10.1164/ajrccm/144.5.1080
19. Kato S, Sugimura H, Kishiro I, Machida M, Suzuki H, Kaneko N: Suppressive effect of pulmonary hypertension and leukocyte activation by inhaled prostaglandin E1 in rats with monocrotaline-induced pulmonary hypertension. Exp Lung Res 2002, 28:265-273. 10.1080/01902140252964357
20. Cox JW, Andreadis NA, Bone RC, Maunder RJ, Pullen RH, Ursprung JJ, Vassar MJ: Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome. Am Rev Respir Dis 1988, 137:5-12. 10.1164/ajrccm/137.1.5
21. Lowson SM: Inhaled alternatives to nitric oxide. Anesthesiology 2002, 96:1504-1513. 10.1097/00000542-200206000-00034
22. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang CT: Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study: the I-NO/PPHN Study Group. Pediatrics 1998, 101:325-334. 10.1542/peds.101.3.325
23. Sadiq HF, Mantych G, Benawra RS, Devaskar UP, Hocker JR: Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial. J Perinatol 2003, 23:98-103. 10.1038/sj.jp.7210878
24. Mercier JC, Thébaud B, Onody P, Storme L, van Overmeire B, Bréart G: Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial: the Franco-Belgium Collaborative NO Trial Group. Lancet 1999, 354:1066-1071.
25. Konduri GG, Solimano A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N, Wright LL, Van Meurs K, Stork E, Kirpalani H, Peliowski A: A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 2004, 113:559-564. 10.1542/peds.113.3.559
26. Sood BG, Peterson J, Malian M, Galli R, Geisor-Walter M, McKinnon J, Sharp J, Maddipati KR: Jet nebulization of prostaglandin E1 during neonatal mechanical ventilation: stability, emitted dose and aerosol particle size. Pharmacol Res 2007, 56:531-541. 10.1016/j.phrs.2007.09.017
27. Piantadosi S: Sample size and power. Wiley Series in Probability and Statistics. In Clinical Trials: A Methodologic Perspective. 2nd edition. Edited by: Balding DJ, Cressie NAC, Fisher NI, Johnstone IM, Kadane JB, Molenberghs G, Ryan LM, Scott DW, Smith AFM, Teugels JL. New Jersey: John Wiley & Sons; 2005:251-308.
28. Stallard N, Whitehead J, Todd S, Whitehead A: Stopping rules for phase II studies. Br J Clin Pharmacol 2001, 51:523-529. 10.1046/j.0306-5251.2001.01381.x
29. Schoenfeld D: Statistical considerations for pilot studies. Int J Radiat Oncol Biol Phys 1980, 6:371-374. 10.1016/0360-3016(80)90153-4
30. Dickson M, Gagnon JP: The cost of new drug discovery and development. Discov Med 2004, 4:172-179.
31. Yoder BA, Gordon MC, Barth WH Jr: Late-preterm birth: does the changing obstetric paradigm alter the epidemiology of respiratory complications? Obstet Gynecol 2008, 111:814-822. 10.1097/AOG.0b013e31816499f4
32. Qureshi FG, Jackson HT, Brown J, Petrosyan M, Rycus PT, Nadler EP, Oyetunji TA: The changing population of the United States and use of extracorporeal membrane oxygenation. J Surg Res 2013, 184:572-576. 10.1016/j.jss.2013.04.027
33. Konduri GG, Sokol GM, Van Meurs KP, Singer J, Ambalavanan N, Lee T, Solimano A: Impact of early surfactant and inhaled nitric oxide therapies on outcomes in term/late preterm neonates with moderate hypoxic respiratory failure. J Perinatol 2013, 33:944-949. 10.1038/jp.2013.83
34. Sood BG, Glibetic M, Aranda JV, Delaney-Black V, Chen X, Shankaran S: Systemic levels following PGE1 inhalation in neonatal hypoxemic respiratory failure. Acta Paediatr 2006, 95:1093-1098. 10.1080/08035250600580511
35. Sood BG, Chen X, Dawe EJ, Malian M, Maddipati KR: Tissue distribution, metabolism and excretion of PGE1 following prolonged high-dose inhalation in neonatal pigs. Int J Pharmacol 2010, 6:224-230.
36. Sood BG, Shen Y, Latif Z, Chen X, Sharp J, Neelavalli J, Joshi A, Slovis TL, Haacke EM: Aerosol delivery in ventilated newborn pigs: an MRI evaluation. Pediatr Res 2008, 64:159-164. 10.1203/PDR.0b013e3181761841
37. Sood BG, Shen Y, Latif Z, Galli R, Dawe EJ, Haacke EM: Effective aerosol delivery during high-frequency ventilation in neonatal pigs. Respirology 2010, 15:551-555. 10.1111/j.1440-1843.2010.01714.x
38. Sood BG, Dawe EJ, Rao Maddipati K, Malian M, Chen X, Galli R, Rabah R: Toxicity of prolonged high dose inhaled PGE1 in ventilated neonatal pigs. Pulmonary Pharmacol Ther 2008, 21:565-572. 10.1016/j.pupt.2008.01.011
39. Dolovich MB, Dhand R: Aerosol drug delivery: developments in device design and clinical use. Lancet 2011, 377:1032-1045. 10.1016/S0140-6736(10)60926-9
40. Ari A, Fink JB, Dhand R: Inhalation therapy in patients receiving mechanical ventilation: an update. J Aerosol Med Pulm Drug Deliv 2012, 25:319-332. 10.1089/jamp.2011.0936
41. Field D, Davis C, Elbourne D, Grant A, Johnson A, Macrae D: UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: UK Collaborative ECMO Trail Group. Lancet 1996, 348:75-82.
42. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, Redding GJ, De Lemos RA, Sardesai S, McCurnin DC, Moreland SG, Cutter GR, Abman SH: Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 1997, 131:55-62. 10.1016/S0022-3476(97)70124-0
43. Adatia I, Haworth SG, Wegner M, Barst RJ, Ivy D, Stenmark KR, Karkowsky A, Rosenzweig E, Aguilar C: Clinical trials in neonates and children: report of the pulmonary hypertension academic research consortium pediatric advisory committee. Pulm Circ 2013, 3:252-266. 10.4103/2045-8932.109931
44. Fike CD, Aschner JL: Spread the word, children are still not "small adults". Pulm Circ 2013, 3:3-4. 10.4103/2045-8932.109909
45. McLaughlin VV, Badesch DB, Delcroix M, Fleming TR, Gaine SP, Galie N, Gibbs JS, Kim NH, Oudiz RJ, Peacock A, Provencher S, Sitbon O, Tapson VF, Seeger W: End points and clinical trial design in pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S97-S107. 10.1016/j.jacc.2009.04.007
46. Grieve AP, Chow SC, Curram J, Dawe S, Harnisch LO, Henig NR, Hung HM, Ivy DD, Kawut SM, Rahbar MH, Xiao S, Wilkins MR: Advancing clinical trial design in pulmonary hypertension. Pulm Circ 2013, 3:217-225. 10.4103/2045-8932.109933
47. Wilkins MR: Developing treatments for pulmonary arterial hypertension. Pulm Circ 2013, 3:156-159. 10.4103/2045-8932.109961
48. Offringa M, van der Lee H: Small sample approach, and statistical and epidemiological aspects. Handb Exp Pharmacol 2011, 205:181-202. 10.1007/978-3-642-20195-0_9
49. Newman JH, Elliott GC, Haworth GS, Zampaglione E, Brar S, Gibbs SJ, Sandoval J: Clinical trials in pulmonary hypertension: time for a consortium. Pulm Circ 2013, 3:245-251. 10.4103/2045-8932.109922